Disc Medicine, Inc. cotiza a 56.60 USD y tiene una capitalización bursátil de $2.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinic…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.54 | $-1.65 | $-1.62 |
| Estimado | $-1.71 | $-1.77 | $-1.73 | $-1.70 |
| Sorpresa | — | +13.0% | +4.6% | +4.7% |
| Métrica | IRON | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -28.7% | -40.4% | +11.7% |
| ROA | -26.3% | -32.0% | +5.7% |
| Current Ratio | 21.94 | 2.84 | +19.10 |
| Debt / Equity | 0.04 | 0.28 | -0.24 |